Works matching IS 02698811 AND DT 2024 AND VI 38 AND IP 4

Results: 9

Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 324, doi. 10.1177/02698811241241384

By:

da Rosa, André Luiz Schuh Teixeira;
Bezerra, Olivia Sorato;
Rohde, Luis Augusto;
Graeff-Martins, Ana Soledade

Publication type:

Article

Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 353, doi. 10.1177/02698811241240308

By:

Chang, Minna;
Chang, Kai Tuomas;
Chang, Fuju

Publication type:

Article

Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 318, doi. 10.1177/02698811241239596

By:

Cortese, Samuele;
Besag, Frank MC;
Clark, Bruce;
Hollis, Chris;
Kilgariff, Joe;
Moreno, Carmen;
Nicholls, Dasha;
Wilkinson, Paul;
Woodbury-Smith, Marc;
Sharma, Aditya

Publication type:

Article

Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 311, doi. 10.1177/02698811241239582

By:

Cortese, Samuele;
Besag, Frank MC;
Clark, Bruce;
Hollis, Chris;
Kilgariff, Joe;
Moreno, Carmen;
Nicholls, Dasha;
Wilkinson, Paul;
Woodbury-Smith, Marc;
Sharma, Aditya

Publication type:

Article

A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 344, doi. 10.1177/02698811241239543

By:

O'Neill, James R.;
Jameson, Adam;
McLean, Samantha L.;
Dixon, Michael;
Cardno, Alastair G.;
Lawrence, Christopher

Publication type:

Article

Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 375, doi. 10.1177/02698811241238284

By:

Rodrigues, Nelson B;
Chen-Li, David;
Di Vincenzo, Joshua D;
Juneja, Ashwin;
Pinder, Benjamin D;
McIntyre, Roger S;
Rosenblat, Joshua D

Publication type:

Article

Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 382, doi. 10.1177/02698811241238283

By:

Jameson, Adam;
Faisal, Muhammad;
Fylan, Beth;
Bristow, Greg C;
Sohal, Jaspreet;
Dalton, Caroline;
Sagoo, Gurdeep S;
Cardno, Alastair G;
McLean, Samantha L

Publication type:

Article

Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 362, doi. 10.1177/02698811241237869

By:

Macoveanu, Julian;
Petersen, Jeff Zarp;
Mariegaard, Johanna;
Jespersen, Andreas Elleby;
Cramer, Katrine;
Bruun, Caroline Fussing;
Madsen, Helle Østergaard;
Jørgensen, Martin Balslev;
Vinberg, Maj;
Fisher, Patrick M;
Knudsen, Gitte Moos;
Hageman, Ida;
Ehrenreich, Hannelore;
Kessing, Lars Vedel;
Miskowiak, Kamilla Woznica

Publication type:

Article

Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 395, doi. 10.1177/02698811241237868

By:

Papic, Ivan;
Bistrovic, Petra;
Krecak, Ivan;
Ortner Hadziabdic, Maja;
Lucijanic, Marko

Publication type:

Article